A business unit of the New York Blood Center Enterprises, Comprehensive Cell Solutions (CCS) is a cell and gene therapy-focused development and manufacturing organization that provides critical capacity to an underserved population of early-stage developers, as well as expertise and strategic footprint for hospital treatment centers and pharmaceutical organizations. With decades of experience, CCs combines the technology, expertise, and capacity you need to bring your novel cell therapies from discovery to commercialization.
Partial Data by Infogroup (c) 2024. All rights reserved.